Loomis Sayles & CO L P Seagen Inc. Transaction History

Loomis Sayles & CO L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$187.64 - $206.25 $3,002 - $3,300	16 New	16 $3,000
Q1 2022 May 13, 2022	SELL	$119.61 - $157.85 $86,717 - $114,441	-725 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $13,259 - $17,749	93 Added 14.72%	725 $112,000
Q2 2021 Aug 13, 2021	SELL	$135.08 - $161.1 $29,312 - $34,958	-217 Reduced 25.56%	632 $100,000
Q1 2021 May 17, 2021	SELL	$137.51 - $190.8 $8,800 - $12,211	-64 Reduced 7.01%	849 $118,000

Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $150,307 - $193,492	913 New	913 $160,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.